Supplements Sold As “Street Drug Alternatives” Draw FDA Warning Letters
This article was originally published in The Tan Sheet
Executive Summary
FDA continued its crackdown on products marketed as "street drug alternatives" with recent warning letters to eight firms promoting such products as dietary supplements